BDBM508733 5-Bromo-6-cyano-3-pyridyl 3-[4-(4-chlorothiazol-2-yl)-1H-1,2,3-triazol-1-yl]-3-deoxy-1-thio-α-D-galactopyranoside::US11046725, Example 6

SMILES OCC1O[C@H](Sc2cnc(C#N)c(Br)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1nc(Cl)cs1

InChI Key InChIKey=CXCUPEGHBWIEBH-AHXITHOBSA-N

Data  2 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 508733   

TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508733(5-Bromo-6-cyano-3-pyridyl 3-[4-(4-chlorothiazol-2-...)
Affinity DataKd:  250nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508733(5-Bromo-6-cyano-3-pyridyl 3-[4-(4-chlorothiazol-2-...)
Affinity DataKd:  68nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent